DFX Intelligence
Borrowers
1,057 borrower groups currently held, grade A and BWhat a borrower group isA borrower group is every spelling of one credit agreement's borrower across the BDCs that hold it (Icefall Parent, Icefall Topco and Icefall Bidco are one). Grade A and B groups are listed; a short one-word stem (grade C) is kept apart and never merged across filers. Principal is the sum of BDC pieces and is a lower bound.Principal and marks are the filers' figures at each BDC's latest quarter end, summed. Maturity is the filer's tagged date or the date written into the identifier; a BDC that tags neither leaves it unstated.
Start from
1,057 borrower groups match
| Borrower | Sponsor | BDCs | Principal held | On cost | Spread | Next maturity | First seen |
|---|---|---|---|---|---|---|---|
| NBH Group LLC Education | unattributed | 2 | at least $21.5M | 94c | 0 pts | Aug 19, 2026 | Sep 30, 2022 |
| Savara, Inc Life sciences · grade B | unattributed | 1 | at least $21.4M | 101c | n/a | Apr 1, 2030 | Dec 31, 2022 |
| Medical Device Inc Life sciences | unattributed | 4 | at least $21.3M | 100c | 1 pts | Jul 11, 2029 | Sep 30, 2023 |
| A••••••• I•• Life sciences · grade B | unattributed | 1 | at least $21.3M | 99c | n/a | Aug 1, 2029 | Sep 30, 2025 |
| N•• H•••••••• L•• Healthcare services | unattributed | 2 | at least $21.2M | 103c | 0 pts | Dec 18, 2030 | Dec 31, 2024 |
| O••••• P••••••••• S•••••••• L•• Healthcare services | unattributed | 2 | at least $21.1M | 101c | 1 pts | May 22, 2030 | Mar 31, 2024 |
| C•••••• H•••••••• B•••• G••• Life sciences | unattributed | 1 | at least $21.1M | 105c | n/a | Jun 28, 2030 | Jun 30, 2023 |
| R•••••• H••••••• L•• Healthcare services | unattributed | 4 | at least $21.0M | 99c | 0 pts | Mar 12, 2027 | Dec 31, 2022 |
| A••••• A••••••••• I•• Healthcare services | unattributed | 2 | at least $20.9M | 101c | 0 pts | Sep 16, 2027 | Sep 30, 2025 |
| A•• O•• B•••• Life sciences | unattributed | 1 | at least $20.8M | 100c | n/a | May 16, 2031 | Jun 30, 2025 |
| C••••••• I•• Healthcare services | unattributed | 2 | at least $20.8M | 98c | n/a | Sep 14, 2027 | Dec 31, 2022 |
| B••••••• I•• Education | unattributed | 2 | at least $20.6M | 99c | 1 pts | Jan 31, 2028 | Mar 31, 2023 |
| G••••••••• I•• Healthcare services · Life sciences | unattributed | 3 | at least $20.4M | 50c | n/a | unstated | Dec 31, 2022 |
| L••••••••• S•••••• L•••••• Life sciences | unattributed | 2 | at least $20.4M | 101c | n/a | Dec 23, 2030 | Dec 31, 2024 |
| D•••••••• P•••• R••••••• L•• Healthcare services | unattributed | 2 | at least $20.4M | 100c | n/a | Jun 14, 2029 | Jun 30, 2024 |
| A•••• E••• M•• H•••••••• L•• Healthcare services | unattributed | 2 | at least $20.1M | 100c | n/a | Mar 25, 2032 | Mar 31, 2026 |
| R•• H•••••••• I•• Life sciences | unattributed | 10 | at least $20.0M | 102c | 0 pts | Dec 23, 2030 | Dec 31, 2021 |
| N••••••••• I•• Life sciences | unattributed | 1 | at least $20.0M | 100c | n/a | May 27, 2030 | Jun 30, 2025 |
| S••••••• P••••••••• I•• Life sciences | unattributed | 1 | at least $20.0M | 105c | n/a | Aug 31, 2030 | Jun 30, 2026 |
| F••••••••• N• Life sciences | unattributed | 1 | at least $20.0M | 100c | n/a | May 7, 2032 | Mar 31, 2025 |
| V••••••••• I•• Life sciences | unattributed | 3 | at least $19.8M | 99c | 0 pts | Sep 30, 2027 | Dec 31, 2022 |
| S••••• S•••••• H••••••• A••••••••• I•• Life sciences | unattributed | 2 | at least $19.8M | 101c | 0 pts | Mar 20, 2030 | Jun 30, 2024 |
| Q•••••• H••••• Healthcare services | Sponsor not establishedpossible: W•••••• P••••• L•• (a company of this name is on the sponsor's portfolio page) | 3 | at least $19.8M | 100c | 0 pts | Dec 22, 2027 | Dec 31, 2022 |
| E•••••••• B••••• I•• Healthcare services | L•••••• G•••• • P•••••••• L••• inferred | 7 | at least $19.8M | 100c | 0 pts | Feb 6, 2033 | Sep 30, 2024 |
| U••••••••• Life sciences | unattributed | 1 | at least $19.7M | 100c | n/a | May 24, 2029 | Dec 31, 2024 |
| A•• S••• R••••••••• L•••••• L•• Healthcare services | unattributed | 3 | at least $19.6M | 100c | 1 pts | May 1, 2030 | Dec 31, 2023 |
| A••••••• O••••• T••••••• I•• Life sciences | unattributed | 1 | at least $19.5M | 106c | n/a | Feb 15, 2029 | Jun 30, 2026 |
| L•• I••••••••• L•• Life sciences | unattributed | 2 | at least $19.4M | 102c | n/a | Nov 3, 2027 | Dec 31, 2024 |
| I•• P••• A••••••••• L•• Healthcare services | unattributed | 2 | at least $19.3M | 100c | n/a | May 19, 2027 | Dec 31, 2022 |
| V•••• M•••••• H•••••••• I•• Healthcare services · Life sciences | Sponsor not establishedpossible: J•• P••••••• L•• (a company of this name is on the sponsor's portfolio page) | 11 | at least $19.2M | 95c | n/a | Oct 29, 2031 | Mar 31, 2022 |
| T•• G••• H••••• G••••• L•• Healthcare services | unattributed | 1 | at least $19.1M | 100c | n/a | Jun 1, 2030 | Jun 30, 2026 |
| M••••• L•••• I•• Healthcare services | unattributed | 1 | at least $19.0M | 99c | n/a | Feb 1, 2029 | Mar 31, 2023 |
| L••• S•••••• I••••••••• H•••••••• L•• Life sciences | unattributed | 3 | at least $18.9M | 100c | n/a | Jun 10, 2027 | Sep 30, 2023 |
| E•• H••••• Life sciences | unattributed | 2 | at least $18.9M | 100c | 0 pts | Aug 7, 2030 | Sep 30, 2024 |
| C••••••••• M••••••••• H•••••••• L•• Healthcare services | unattributed | 4 | at least $18.9M | 101c | n/a | Jan 31, 2029 | Mar 31, 2024 |
| T••••••• H••••• C••• P••••••• I•• Life sciences | Sponsor not establishedpossible: N•• W•••• C••••••• L••• (a company of this name is on the sponsor's portfolio page) | 2 | at least $18.8M | 99c | 0 pts | Aug 6, 2031 | Mar 31, 2025 |
| T••••••• T••••••••• L•••••• Life sciences | unattributed | 1 | at least $18.8M | 98c | n/a | Oct 1, 2029 | Mar 31, 2026 |
| P•• B••••• L•• Healthcare services | unattributed | 3 | at least $18.6M | 100c | n/a | May 4, 2028 | Dec 31, 2022 |
| C••• R••••••• L• C••••••• S••••••• H•••••••• I•• Healthcare services | unattributed | 1 | at least $18.3M | 74c | n/a | Jun 16, 2029 | Dec 31, 2022 |
| T••• N••• I••• D••• a•• E••••• I••• K••• L•• Healthcare services | unattributed | 1 | at least $18.2M | 99c | n/a | Dec 20, 2026 | Jun 30, 2026 |
| P••••••• C••• H•••••••• L•• Healthcare services | unattributed | 2 | at least $18.1M | 99c | n/a | Mar 17, 2029 | Jun 30, 2023 |
| P•••••• D••••• C••• M••••••••• L•• Life sciences | unattributed | 1 | at least $18.1M | 100c | n/a | Aug 31, 2027 | Dec 31, 2022 |
| N•••• S••••••• I•• Life sciences | unattributed | 2 | at least $17.8M | 99c | 2 pts | Jan 7, 2031 | Mar 31, 2025 |
| A••••••••• I•• Life sciences | Sponsor not establishedpossible: V••••• G••••• I•••••••• L• (a company of this name is on the sponsor's portfolio page) | 1 | at least $17.5M | 100c | n/a | Jun 1, 2029 | Jun 30, 2025 |
| e••••• T••••••••• I•• Life sciences | unattributed | 1 | at least $17.5M | 100c | n/a | Jan 1, 2030 | Jun 30, 2026 |
| e•••••• I•• Life sciences · grade B | unattributed | 1 | at least $17.5M | 103c | n/a | Jan 1, 2030 | Dec 31, 2022 |
| M•• D••••• Life sciences | W•••••• P••••• L•• inferred | 3 | at least $17.3M | 101c | 0 pts | Feb 13, 2031 | Dec 31, 2023 |
| B••••••• B••••• I•• Healthcare services | unattributed | 3 | at least $17.3M | 100c | 0 pts | Apr 30, 2032 | Dec 31, 2025 |
| B•••• T••••••••• P•••• Life sciences | Sponsor not establishedpossible: A•••• W••• G•••••• L• (a company of this name is on the sponsor's portfolio page) | 1 | at least $17.3M | 99c | n/a | Oct 1, 2029 | Dec 31, 2025 |
| T•••• H••••••••• B••••• L•• Healthcare services | unattributed | 2 | at least $17.2M | 95c | n/a | Feb 27, 2030 | Mar 31, 2024 |
The borrower, lender and sponsor names past the first 3 rows are hidden. Open a row to reveal that record with a free account (5 a month), or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source is public either way.